Atlantic Therapeutics Primed To Launch Novel Therapeutic Device For Stress Urinary Incontinence
INNOVO was approved by the United States Food and Drug Administration (FDA) on November 13, 2018, and is the first ever transcutaneous electrical stimulator cleared by the FDA, offering U.S. women a safe, clinically effective and non-invasive choice to treat stress urinary incontinence (SUI).
- INNOVO was approved by the United States Food and Drug Administration (FDA) on November 13, 2018, and is the first ever transcutaneous electrical stimulator cleared by the FDA, offering U.S. women a safe, clinically effective and non-invasive choice to treat stress urinary incontinence (SUI).
- Atlantic Therapeutics develops professional and consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor.
- Dmochowski Novel external electrical muscle stimulation device for the treatment of female stress urinary incontinence: randomized controlled noninferiority trial versus intravaginal electrical stimulation.
- What is Stress Urinary Incontinence (SUI)?.